ADVIA® Chemistry CA_2c Calcium_2 Reagents, Concentrated - Arsenazo III 10283344Recalls & reported problems
Siemens Healthcare Diagnostics Inc. · Calcium - ADVIA Chem. - RGT - 4x1700 tests · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00630414553160), received between Jun 7, 2018 and Feb 10, 2025 — classified as 2 malfunctions.
The most frequently reported specific device problem is “High Test Results” (1 report).
1 other recall cover devices cleared under the same FDA submission (K083386); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- High Test Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 10, 2025High Test Results; High Test Results
THE CUSTOMER REPORTED THAT TWO PATIENT SAMPLES GAVE FALSELY ELEVATED CALCIUM (CA_2C) TEST RESULTS FROM AN ADVIA CHEMISTRY XPT SYSTEM. THE FALSELY ELEVATED PATIENT RESULTS WERE NOT REPORTED TO THE PHYSICIAN(S). THE SAME SAMPLES WERE REPEATED ON AN ALTERNATE ADVIA CHEMISTRY XPT SYSTEM. THE REPEAT RESULTS WERE LOWER, CONSIDERED CORRECT AND REPORTED TO THE PHYSICIAN(S). THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE FALSELY ELEVATED CA_2C RESULTS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21347427 ↗MalfunctionJun 7, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DISCORDANT FALSELY LOW RESULTS WERE OBTAINED ON FOUR PATIENT SAMPLES ON AN ADVIA CHEMISTRY XPT SYSTEM WHEN USING CALCIUM_2 CONCENTRATED ASSAY (CA_2C) REAGENT LOT 424014. THE 4 PATIENT SAMPLES WERE REPEATED AGAIN ON THE SAME INSTRUMENT AND THE RESULTS WERE ACCEPTABLE. THE INITIAL FALSELY LOW RESULTS FOR THE 4 PATIENTS WERE REPORTED TO THE PHYSICIAN(S), AND NOT QUESTIONED. THE CORRECTED REPEAT RESULTS WERE REPORTED TO THE PHYSICIAN(S). THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE FALSELY LOW RESULTS OBTAINED FOR THE CA_2 ASSAY.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7579689 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K083386. One submission often covers many models, so check the product and lot details in each record.
- Z-0928-2022 · Feb 9, 2022 · Open, ClassifiedAtellica CH Calcium_2 (CA_2), Siemens Material Number 11097644
Other AZO DYE, CALCIUM devices
- VITROS 1450261Ortho-Clinical Diagnostics, Inc. · AZO DYE, CALCIUM2 recalls7 reports
- Atellica CH CA_2 11097644Siemens Healthcare Diagnostics Inc. · AZO DYE, CALCIUM1 recall28 reports
- Alinity 07P5720Abbott GmbH · AZO DYE, CALCIUM55 reports
- Alinity 07P5730Abbott GmbH · AZO DYE, CALCIUM51 reports
- ARCHITECT 3L79-21Abbott Laboratories · AZO DYE, CALCIUM30 reports
- ARCHITECT 3L79-31Abbott Laboratories · AZO DYE, CALCIUM24 reports
- ARCHITECT 3L79-22Abbott GmbH · AZO DYE, CALCIUM17 reports
- ARCHITECT 3L79-32Abbott GmbH · AZO DYE, CALCIUM15 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page